Oppenheimer analyst Leland Gershell raised the price target on Ascendis Pharma (NASDAQ: ASND) to $212.00 (from $208.00) while maintaining an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE